Timothy Moseley

Timothy Moseley

Company: Direct Biologics

Job title: Chief Scientific Officer

Seminars:

A Non-Conventional Pathway to Commercialize an EV Therapeutic 9:30 am

MSC secretome: Cell therapy without the cells Navigating Direct Biologics’ pathway to phase III clinical trial Leveraging nature’s mechanism of action for disease mitigation NEW DATA!Read more

day: Conference Day One

Biopharma Leaders Panel Discussion: Unlocking the Next Wave of Safe & Efficient Exosome-Based Therapeutics Towards Clinical & Commercial Reality 1:30 pm

This is your chance to hear from pioneering executive leaders from the exosome and extra-cellular vesicle community who will discuss their strategies, challenges, and future perspectives for exosome technology and clinically relevant therapeutic applications. What are the future opportunities, promising targets, and applications on the horizon for exosomes to achieve clinical success? What can we…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.